Eduardo Ortega-Collazos

Mr. Eduardo Ortega-Collazos

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in International Journal of Biometeorology
Verified
Journal Article
Open access
PDF file
EOEduardo Ortega-Collazos
Eduardo Ortega-Collazos
ECEduardo Otero Calderón
Eduardo Otero Calderón
CLCasimiro Fermín López-Jurado
Casimiro Fermín López-Jurado
MNMaría del Carmen Navarro
María del Carmen Navarro
LMLeticia Martín-Cordero
Leticia Martín-Cordero
MSMARIA DOLORES HINCHADO SANCHEZ-MORO
MARIA DOLORES HINCHADO SANCHEZ-MORO
Balneotherapy using peloids (mud-bath therapy) is one of the most effective non-pharmacological approaches for managing osteoarticular and musculoskeletal disorders, such as osteoarthritis (OA). Recent studies have shown that peloids enriched with rosmarinic acid (RosA) enhance the therapeutic effects of mud therapy in elderly OA patients. The objective of this study was to evaluate whether the normalization of the interaction between the hormetic stress response, mediated by cortisol, and the inflammatory response, mediated by IL-8 (measured in blood by ELISA), underlies the clinical benefits of a hyperthermic mud-bath intervention using a RosA-enriched peloid, a polyphenolic acid with anti-inflammatory and immunomodulatory properties. Additionally, we aimed to investigate whether this neuroimmune regulation contributes to enhancing the innate immune response, specifically the phagocytic and microbicidal activity of neutrophils (assessed by flow cytometry). Twenty-three elderly OA patients participated in the mud-bath intervention, a 10-day cycle of hyperthermic balneotherapy using a RosA-fortified peloid and mineral medicinal water at 40 °C. Significant increases in systemic cortisol levels, along with a notable decrease in IL-8 and enhanced phagocytic and microbicidal activity of neutrophils, were observed following the intervention. These effects were accompanied by improved knee mobility and reduced pain. In conclusion, hyperthermic mud-bath therapy with a RosA-enriched peloid induces immunoneuroendocrine stabilization, which underlies the clinical benefits of the balneological intervention. Finally, concepts such as neuroimmunomodulation, hormesis, and the bioregulation of the innate and inflammatory immune responses in the context of balneotherapy are also discussed.

22 December 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
EOEduardo Ortega-Collazos
Eduardo Ortega-Collazos
MSMARIA DOLORES HINCHADO SANCHEZ-MORO
MARIA DOLORES HINCHADO SANCHEZ-MORO
ECEduardo Otero Calderón
Eduardo Otero Calderón
CLCasimiro Fermín López-Jurado
Casimiro Fermín López-Jurado
IGIsabel Gálvez
Isabel Gálvez
STSilvia Torres-Piles
Silvia Torres-Piles
Osteoarthritis (OA) is a common chronic condition that causes pain and disability, particularly in the elderly, resulting in significant limitations on mobility and overall quality of life. Balneotherapy using peloids (mud therapy) is an effective, non-pharmacological treatment for OA that improves symptoms and function. This pilot study aimed to assess whether a controlled-matured peloid, supplemented with rosmarinic acid (RosA), could enhance clinical outcomes, functional status, and immune response in OA patients. The study involved 42 elderly OA patients (mean age 70), comparing a 10-day balneotherapy cycle using either a RosA-fortified or non-fortified peloid. The effects on pain (Visual Analogue Scale), functional status (WOMAC, knee flexion/extension), quality of life (EUROQOL), and innate immune response (neutrophil phagocytic and microbicidal activity) were evaluated. Both treatments resulted in significant improvements in pain (by approximately 60%), function, and quality of life, but the RosA-fortified peloid led to greater benefits, particularly in the anxiety/depression dimension of the EUROQOL questionnaire and in enhancing neutrophil immune responsiveness. These findings suggest that RosA supplementation may further improve the therapeutic effects of mud therapy for OA management.